InsidersTradesSigma
Follow the Theralase Technologies Inc. stock price and the full insider trade history of the company, a listed issuer based in Canada. Shares are quoted on CA CA, under the oversight of SEDI. The latest transaction was disclosed on 10 August 2026 (50 - Grant of options). Among the most active insiders: Bruder, Randall. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
5 of 5 declarations
Theralase Technologies Inc. is a Canadian company focused on developing medical technologies, particularly laser treatment systems. It aims to eradicate cancer and manage pain.